https://nl.marketscreener.com/koers/aandeel/MINERALYS-THERAPEUTICS-IN-150491009/nieuws/Mineralys-Therapeutics-Inc-Presenteert-nieuwe-post-hoc-analyse-van-de-Target-HTN-Fase-2-studie-met-45226178/?utm_source=telegram&utm_medium=social&utm_campaign=share